- Member Center
- Professional Groups
The 2016 IP100 Executive Forum
|Meeting Home||Program||Keynote Speakers||Panelists||Sponsors|
|Hotel Information||Continuing Education||Advisory Board||Attendee Eligibility|
Peter, President of ipCreate, has more than 25 years in the investment and monetization of IP, from tech and patent licensing, to patent sales, IP venturing and IP Fund formation. He has a worldwide reputation for creating IP value and delivering top-quartile returns without litigation.
Prior to joining ipCreate, Peter was the Senior Vice President of Investments and Acquisitions at IPVALUE Management, Inc., a Goldman Sachs / General Atlantic backed IP monetization company which has generated over $1.3 Billion of IP revenues. In 2007, he was the founder and Managing Director of the IP Investment Group at Coller Capital Inc., a global Private Equity firm with over $18 Billion under management. In 1999, he was the founder and Managing Director of Invisible Hand LLC, a $48 Million IP venturing fund. In 1995, he was the SVP & Officer with University Patents, Inc., an AMEX listed outsourced university technology and patent licensing organization representing 30+ universities.
In 1990, Peter was the Global Technology Acquisitions & Partnerships Manager with Matsushita Electric (Panasonic) in Osaka, Japan. In 2014, he was chosen by Intellectual Asset Management Journal as the global top 40 most influential people in IP. In 2014, Peter was honored and awarded by The Korean Government for contributions to the monetization of Korean R&D globally.
Peter was also formerly a Research Fellow at Tokyo University and Senior Fellow at Wharton Business School.
Nola Masterson is an experienced global executive and board leader serving on public company, venture-backed private company and non- profit organization boards. Her successful business experience, as CEO and co- founder of Sequenom, (SQNM) and the first analyst in biotechnology on Wall Street with Drexel Burnham Lambert and Merrill Lynch, followed successful business building at Millipore for eight years. She has experience in managing her own venture fund, as well as being a Venture Partner in a major European IT and life sciences venture fund, TVM Capital. During her 10 years on the Repros Therapeutics (RPRX) Board she has advised the CEO on strategy, finance, operations, and recruitment of the board. Areas of expertise include medical device, pharmaceuticals, scientific tools, separation processes and diagnostics technology as well as genetic analysis.
One of Ms. Masterson’s strengths is that she understands, at several levels, the “DNA” of what makes a great company. Her leadership style is as a synthesizer, to create a professional Board environment that is aligned with, and which contributes to the success of, companies at every stage in their development.
Ms. Masterson has been certified by the American College of Corporate Directors for 2014 as a Certified Professional Director, and is listed in the Intrabond.com Capital Registry of Corporate Directors. She also has experience in CEO and other senior executive, and board position recruitment and transition processes, and in building productive board cultures.
Ms. Masterson started her own venture fund in 1998. As a venture investor, she served on the Board of EpiCept Corporation, which was focused on vascular disruptive agents, while it was a private company, and on the Board of Nanostream, Inc., a venture backed company focused on assay detection, liquid chromatography, and sample preparation. She served on the Board of Omicia, Inc, a genomics translation company for 7 years. Her experience as CEO of Sequenom helped her understand NGS, and the software needed to support its translation to medicine.
She currently is the Managing Director of Science Futures Management Company and works as an advisor, board member and investor. She is Chair of the Board of Repros Therapeutics serves as Chair of the Compensation Committee of the company and sits on the Audit Committee. She also serves on the Board of Zivo Biosciences, a public company headquartered in Detroit MI. She also has served on the Board of Generex Biotechnology Corporation, a Toronto, Canada-based publically traded (NASDAQ: GNBT) company focused on the development of drug delivery systems and antigen technologies, and served on the Audit, and Compensation Committee and Chaired the Nomination And Governance Committee of the Generex Board. She is a special advisor to several private companies and is Chair Emeritus of the BayBio Institute, a best-practices and workforce development arm of the Northern California life sciences industry association. Currently she is an Adjunct Professor at University of San Francisco in the School of Business Management, teaching the Business of Biotech. She lectures and writes for the Life Science Foundation.
Ms. Masterson also serves on the Silicon Valley Chapter Board of the American Diabetes Association, and is an avid horseback rider and enjoys singing, oil painting and scuba diving.